Related by context. Frequent words. (Click for all words.) 70 Dialysis Patients 69 Lung Cancer Patients 69 Patients Undergoing 68 Prostate Cancer Patients 68 Survival Rates 68 Patients Treated 67 Cancer Treatments 67 Regimens 67 Elderly Patients 66 Heart Failure Patients 66 Breast Cancer Treatment 65 Advanced Prostate Cancer 65 Clinical Trial Results 65 Completes Enrollment 65 Patient Outcomes 65 Metastatic Melanoma 65 Patient Enrollment 64 Cardiovascular Events 64 FDA Clears 64 Preclinical Data 64 Breast Cancer Patients 64 Gastric Cancer 64 Cents Per Share 63 Urinary Incontinence 63 Month Period Ended 63 Upcoming Conferences 63 Cholesterol Drug 63 Venous Thromboembolism 63 Overactive Bladder 63 Phase III Clinical Trial 63 Clinical Trials Update 63 Varicose Veins 63 Newly Diagnosed 62 Pivotal Phase 62 Chronic Lymphocytic Leukemia 62 Postmenopausal Women 62 Early Diagnosis 62 Pivotal Phase III 62 Well Tolerated 62 Prostate Cancer Treatment 62 Meta Analysis 62 Chronic Hepatitis C 62 Blood Clots 61 Randomized Controlled Trial 61 Diabetic Patients 61 Upcoming Investor Conferences 61 Drug Candidate 61 Presents Positive 61 Autoimmune Disease 61 Metastatic Colorectal Cancer 61 Cancer Therapies 61 Post Operative 60 Cancer Diagnosis 60 Phase III Trial 60 Hormone Therapy 60 Six Weeks Ended 60 Study Demonstrates 60 Clinical Outcomes 60 Receives FDA Clearance 60 Announces Presentation 59 Systematic Review 59 Pulmonary Arterial Hypertension 59 Bladder Cancer 59 Face Transplant 59 Medication Errors 59 Pivotal Trial 59 II Clinical Trial 58 Thyroid Cancer 58 Benign Prostatic Hyperplasia 58 Life Threatening 58 Acute Myocardial Infarction 58 Combination Therapy 58 Stem Cell Transplant 58 Drug Resistant 58 Breast Reconstruction 58 Brain Tumors 58 Initiate Phase 58 Record Second Quarter 57 Month Period 57 Three Months Months Ended 57 Autoimmune Diseases 57 Community Acquired Pneumonia 57 Generic Version 57 RNAi Therapeutics 57 Conjoined Twins 57 Drug Eluting Stent 57 Blood Vessel 57 Hepatitis C Virus 57 Investor Conferences 57 Monotherapy 57 Annual Meeting Date 57 Fiscal Third Quarter 57 Radiation Exposure 57 Holds Promise 57 Insulin Resistance 57 Unaudited Fourth Quarter 57 Exelixis Announces 56 Record Third Quarter 56 Shows Promise 56 Hip Replacement 56 FDA Clearance